David William Fennelly

Title: David William Fennelly: Innovator in Cancer Treatment

Introduction

David William Fennelly is a notable inventor based in New York, NY (US). He has made significant contributions to the field of cancer treatment, particularly in the area of breast cancer therapy. His innovative approach has the potential to improve outcomes for patients suffering from this challenging disease.

Latest Patents

Fennelly holds a patent for a combination therapy method for treating breast cancer using edatrexate. This invention provides combination therapy methods, pharmaceutical combinations, and compositions for inducing tumor cell regression in cancer patients, particularly those with metastatic breast cancer. The combination methods, combinations, and compositions employ both edatrexate and a taxane, which are administered simultaneously or sequentially. This therapy allows for the administration of unusually high doses of edatrexate, offering new hope for patients.

Career Highlights

David William Fennelly is associated with the Sloan-Kettering Institute for Cancer Research, where he works on advancing cancer treatment methodologies. His research and innovations have contributed to the understanding and treatment of breast cancer, making a significant impact in the medical community.

Collaborations

Fennelly collaborates with esteemed colleagues, including Francis M. Sirotnak, to further enhance cancer treatment strategies. Their combined expertise fosters an environment of innovation and discovery in the fight against cancer.

Conclusion

David William Fennelly's work exemplifies the spirit of innovation in the medical field. His contributions to cancer treatment through his patented methods highlight the importance of research and collaboration in developing effective therapies. His dedication to improving patient outcomes continues to inspire advancements in cancer care.